Company / PP&E per Share
NovaBay Pharmaceuticals, Inc. PP&E per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2024
5-year range
$0.00 / $0.06
FY2020-FY2024
Trend
+40.0%
vs FY2023
Sector context
#158 of 193
Health Care
What the data says
NovaBay Pharmaceuticals, Inc.'s pp&e per share of $0.01 is lower than 82% of companies in the Health Care sector (FY2024). PP&E per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2020 to $0.19 in FY2015.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of +16.4%.
Declined from $0.06 to $0.01 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +34.9%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 193This company $0.01 Sector average $18.71
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, pp&e per share increased 40.0% year-over-year.
- Ranks #158 out of 193 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2015.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.01 | +40.0% |
| FY2023 | $0.01 | -86.8% |
| FY2022 | $0.06 | +1222.8% |
| FY2021 | $0.00 | +84.6% |
| FY2020 | $0.00 | -52.9% |
| FY2019 | $0.01 | -56.9% |
| FY2018 | $0.01 | -61.8% |
| FY2017 | $0.03 | -71.0% |
| FY2016 | $0.11 | -44.3% |
| FY2015 | $0.19 | +1856.8% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026